Malignant mixed müllerian tumor of the fallopian tube

Cancer. 1993 Jan 1;71(1):187-92. doi: 10.1002/1097-0142(19930101)71:1<187::aid-cncr2820710129>3.0.co;2-c.

Abstract

Background: Malignant mixed müllerian tumor (MMT) of tubal origin is rare and optimal therapy is unknown.

Methods: Five new cases of MMT of the fallopian tube are presented, and the previous literature is reviewed.

Results: Eight of 10 patients disease-free at 36 months had long-term cancer-free survival. Surgery alone was inadequate therapy even for those with apparent Stage I disease. Five of six treated postoperatively with radiation and chemotherapy have lived disease-free for at least 45 months.

Conclusions: Combination radiation and chemotherapy may offer improved outcome.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Fallopian Tube Neoplasms / mortality
  • Fallopian Tube Neoplasms / pathology*
  • Fallopian Tube Neoplasms / therapy
  • Female
  • Humans
  • Middle Aged
  • Neoplasms, Germ Cell and Embryonal / mortality
  • Neoplasms, Germ Cell and Embryonal / pathology*
  • Neoplasms, Germ Cell and Embryonal / therapy
  • Radiotherapy Dosage